Highbridge Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Highbridge Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Hold	0	–	–	–	294
2024 Q3	–	Hold	0	–	–	–	323
2024 Q2	–	Hold	0	–	–	–	290
2024 Q1	–	Hold	0	–	–	–	209
2023 Q4	–	Hold	0	–	–	–	296
2023 Q3	–	Hold	0	–	–	–	268
2023 Q2	–	Hold	0	–	–	–	287
2023 Q1	–	Hold	0	–	–	–	421
2022 Q4	–	Hold	0	–	–	–	452
2022 Q3	–	Hold	0	–	–	–	650
2022 Q2	–	Hold	0	–	–	–	589
2022 Q1	–	Hold	0	–	–	–	627
2021 Q4	–	Hold	0	–	–	–	466

Other funds holding CEROW

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Q Global Advisors Fort Worth, Texas $157M AUM 29.28% 1-Year Est. Return